Cannabinoids and glaucoma


Autoria(s): Azuara-Blanco, A.; Tomida, I.; Perlwee, R.G.
Data(s)

01/05/2004

Resumo

Glaucoma is one of the leading causes of blindness in the world. In spite of the diverse therapeutic possibilities, new and better treatments for glaucoma are highly desirable. Cannabinoids effectively lower the intraocular pressure (IOP) and have neuroprotective actions. Thus, they could potentially be useful in the treatment of glaucoma. The purpose of this article is to provide the reader with an overview of the latest achievements in research into the potential use of cannabinoids for glaucoma.

Identificador

http://pure.qub.ac.uk/portal/en/publications/cannabinoids-and-glaucoma(d50f319a-0d96-432f-a2c1-4c3a83e06c0e).html

http://dx.doi.org/10.1136/bjo.2003.032250

http://www.scopus.com/inward/record.url?partnerID=yv4JPVwI&eid=2-s2.0-1942517916&md5=e2f5ebfc24d7649c2d71c93e3df4d783

Idioma(s)

eng

Direitos

info:eu-repo/semantics/restrictedAccess

Fonte

Azuara-Blanco , A , Tomida , I & Perlwee , R G 2004 , ' Cannabinoids and glaucoma ' British journal of ophthalmology , vol 88 , no. 5 , pp. 708-713 . DOI: 10.1136/bjo.2003.032250

Tipo

article